Tin tức & Cập nhật

Vaccination against hepatitis E appears to provide up to 10 years of protection, with vaccine-induced antibodies persisting for at least 8.5 years, as shown in a study from China.

Adults with inflammatory bowel disease (IBD) benefit from COVID-19 vaccination, with its protective effect lasting up to 52 weeks postvaccination even among vulnerable populations such as corticosteroid users and older individuals, according to a study.

Concomitant administration of vancomycin (VAN) and piperacillin/tazobactam (PTZ) appears to contribute to a heightened risk of acute kidney injury (AKI) in adult patients in the general ward, results of a study have shown. In addition, VAN+PTZ is associated with more severe AKI.

A Hong Kong study finds no association between the BNT162b2 and CoronaVac vaccines and subclinical progression of MRI cerebrovascular disease biomarkers in community-dwelling adults.

The risk of developing serious infections is much lower among patients with Crohn’s disease (CD) who showed response to adalimumab therapy than nonresponders, after accounting for disease severity, according to the results of a study presented at CCC 2024.

Exposure to potassium-competitive acid blockers (PCABs) may heighten the risk of developing gastric cancer after successful treatment for Helicobacter pylori infection, according to a study.

Use of topical mupirocin prophylaxis is feasible and has an acceptable safety profile for the long-term prevention of indwelling pleural catheter (IPC)- or indwelling peritoneal catheter (IPeC)-related infections, results of a pilot study have shown.